4.7 Article

Anticancer properties, apoptosis and catecholase mimic activities of dinuclear cobalt(II) and copper(II) Schiff base complexes

Journal

BIOORGANIC CHEMISTRY
Volume 95, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2019.103561

Keywords

Schiff base complexes; Anticancer activity; Apoptosis; Catecholase activity; DFT

Funding

  1. DST-SERB, New Delhi [EMR/2016/005805, ECR/2016/001111]
  2. DST-FIST program of Department of Chemistry, AMU, Aligarh
  3. DST-PURSE program of Department of Chemistry, AMU, Aligarh
  4. UGC-DSR (SAP-II) program of Department of Chemistry, AMU, Aligarh

Ask authors/readers for more resources

The present work describes coordination chemistry and biological evaluation of two novel dinuclear complexes [Co-2(HL1)(2)(H2O)(2)]center dot 8H(2)O (1) and [Cu-2(L-2)(2)] (2) obtained from the Schiff base ligands, H3L1 and H2L2 (formed in situ). The two complexes are characterized by single crystal X-ray, spectral and variable temperature magnetic and theoretical (DFT/TDDFT) analysis. X-ray analysis confirms both the complexes to be dinuclear with distorted octahedral and square pyramidal geometry around Co(II) and Cu(II) ions, respectively. Magnetic studies reveal presence of moderate ferromagnetic interactions in both the complexes with J = 98 (1) and 32 (2) cm(-1). The magnetic interactions are further corroborated by DFT studies. Co(II) complex (1) exhibited enhanced catecholase activity with K-cat = 213.48 h(-1), which is attributed to the greater extent of charge contribution on Co2+ as compared to Cu2+ as determined by DFT calculations. Furthermore, both the complexes show potent anticancer activity toward HeLa (cervical) and A549 (lung) cancer cell lines with IC50 = 6-7 mu M at 48 h, which ascertains both the complexes as better anticancer drugs than cisplatin. Furthermore, 1 and 2 exhibit apoptosis of HeLa cells by demonstrating nuclear blebbings with shrinking morphology. Hence, the present complexes could be employed as a model for metalloenzymes as well as potential anticancer substituents of cisplatin in future course.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available